Skip to main content

TB and COVID-19 co-infection: rationale and aims of a global study

Buy Article:

$24.29 + tax (Refund Policy)

No Abstract

Document Type: Letter to the Editor

Affiliations: 1: Argentina 2: New South Wales, Australia 3: Belarus 4: Belgium 5: Brazil 6: Ontario, Canada 7: Chile 8: Zhejiang, China 9: Colombia 10: France 11: India 12: Greece 13: Guinea Republic 14: Honduras 15: Latvia 16: Lithuania 17: Mexico 18: Netherlands 19: Niger 20: Panama 21: Paraguay 22: Peru 23: Portugal 24: Romania 25: Arkhangelsk, Volvograd, Moscow, Russian Federation 26: Serbia 27: Singapore 28: Slovakia 29: South Africa 30: Spain 31: Sweden 32: Switzerland 33: UK 34: Uruguay 35: Virginia, USA

Publication date: January 1, 2021

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content